Aspivix
Startup manufacturing non-traumatic medical devices for gynecology
Aspivix has raised €4.8M across 1 funding round from 4 investors, most recently a Series A round in Nov 2022. Based in Renens, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Renens, Switzerlandwww.aspivix.com ↗
Total raised
€4.8M
€4,845,431
Funding rounds
1
Investors
4
distinct backers
Active since
2022-11
latest 2022-11
Funding by year
EUR raised per yearAspivix — funding by year — interactive chart.
Data table
| Aspivix — funding by year | |
|---|---|
| 2022 | €4.8M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-17 | Series A | €4.8M | 4FOx ventures,Hemex,LaunchPad APAC,Zürcher Kantonalbank | View deal → |
Related news
- USD 5 million to speed ASPIVIX entry on European and US Marketsstartupticker.ch · 2022-11
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData